Amneal Pharmaceuticals, Inc. (AMRX)

USD 7.69

(-4.71%)

Total Debt Summary of Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc.'s latest annual total debt in 2023 was 2.75 Billion USD , down -3.33% from previous year.
Amneal Pharmaceuticals, Inc.'s latest quarterly total debt in 2024 Q2 was 2.72 Billion USD , down -0.75% from previous quarter.
Amneal Pharmaceuticals, Inc. reported annual total debt of 2.84 Billion USD in 2022, down -1.08% from previous year.
Amneal Pharmaceuticals, Inc. reported annual total debt of 2.87 Billion USD in 2021, down -2.2% from previous year.
Amneal Pharmaceuticals, Inc. reported quarterly total debt of 2.74 Billion USD for 2024 Q1, down -0.17% from previous quarter.
Amneal Pharmaceuticals, Inc. reported quarterly total debt of 2.8 Billion USD for 2023 Q3, down -1.89% from previous quarter.

Annual Total Debt Chart of Amneal Pharmaceuticals, Inc. (2023 - 2015)

Historical Annual Total Debt of Amneal Pharmaceuticals, Inc. (2023 - 2015)

Year	Total Debt	Total Debt Growth
2023	2.75 Billion USD	-3.33%
2022	2.84 Billion USD	-1.08%
2021	2.87 Billion USD	-2.2%
2020	2.94 Billion USD	6.32%
2019	2.76 Billion USD	2.77%
2018	2.69 Billion USD	81.27%
2017	1.48 Billion USD	0.0%
2016	- USD	0.0%
2015	- USD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	2.72 Billion USD	-0.75%
2024 Q1	2.74 Billion USD	-0.17%
2023 Q3	2.8 Billion USD	-1.89%
2023 Q2	2.85 Billion USD	0.19%
2023 FY	2.75 Billion USD	-3.33%
2023 Q1	2.85 Billion USD	0.29%
2023 Q4	2.75 Billion USD	-1.93%
2022 Q4	2.84 Billion USD	-0.43%
2022 Q3	2.85 Billion USD	-1.43%
2022 Q2	2.89 Billion USD	1.13%
2022 FY	2.84 Billion USD	-1.08%
2022 Q1	2.86 Billion USD	-0.34%
2021 Q4	2.87 Billion USD	5.23%
2021 Q1	2.92 Billion USD	-0.71%
2021 Q2	2.91 Billion USD	-0.08%
2021 FY	2.87 Billion USD	-2.2%
2021 Q3	2.73 Billion USD	-6.32%
2020 Q3	2.96 Billion USD	-0.44%
2020 Q1	3.27 Billion USD	18.56%
2020 Q4	2.94 Billion USD	-0.69%
2020 FY	2.94 Billion USD	6.32%
2020 Q2	2.97 Billion USD	-9.3%
2019 Q2	2.78 Billion USD	-0.34%
2019 FY	2.76 Billion USD	2.77%
2019 Q4	2.76 Billion USD	-0.25%
2019 Q3	2.77 Billion USD	-0.34%
2019 Q1	2.79 Billion USD	3.73%
2018 Q4	2.69 Billion USD	-6.38%
2018 FY	2.69 Billion USD	81.27%
2018 Q3	2.87 Billion USD	3.42%
2018 Q2	2.77 Billion USD	87.62%
2018 Q1	1.48 Billion USD	-0.21%
2017 Q3	- USD	0.0%
2017 Q1	- USD	0.0%
2017 Q4	1.48 Billion USD	0.0%
2017 FY	1.48 Billion USD	0.0%
2016 FY	- USD	0.0%
2016 Q4	- USD	0.0%
2015 FY	- USD	0.0%

Peer Total Debt Comparison of Amneal Pharmaceuticals, Inc.

Name	Total Debt	Total Debt Difference
Bausch Health Companies Inc.	22.38 Billion USD	87.714%
Catalent, Inc.	4.98 Billion USD	44.857%
Emergent BioSolutions Inc.	877.5 Million USD	-213.45%
Elanco Animal Health Incorporated	5.77 Billion USD	52.364%
Perrigo Company plc	4.07 Billion USD	32.476%
Teva Pharmaceutical Industries Limited	20.15 Billion USD	86.352%
Zoetis Inc.	6.8 Billion USD	59.569%